DexCom (DXCM) Earnings Analysis

DexCom (DXCM) next reports earnings on 2026-07-30, consensus EPS 0.61 USD. Last quarter (2026-04-30) it beat with EPS 0.56 USD vs 0.4656 USD est (+20.3%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E 29.76.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DXCM next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate0.61 USD
Revenue estimate1.29B

DXCM earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-300.56 USD0.4656 USD+20.3%Beat
2026-02-120.68 USD0.65 USD+4.6%Beat
2025-10-300.61 USD0.576 USD+5.9%Beat
2025-07-300.48 USD0.4436 USD+8.2%Beat
2025-05-010.32 USD0.3272 USD-2.2%Miss
2025-02-130.45 USD0.4792 USD-6.1%Miss
2024-10-240.45 USD0.44 USD+2.3%Beat
2024-07-250.43 USD0.39 USD+10.3%Beat

Beat rate: 6/8 (75%) over reported quarters with consensus data.

DXCM valuation and analyst view

Trailing P/E29.76
Trailing EPS2.416 USD
Price / book9.30
Dividend yield0.00%
Market cap27.85B
Analyst consensusBuy (42 buy / 8 hold / 2 sell)
Avg price target83.2 USD

Related research pages

Frequently asked questions

When is DexCom (DXCM)'s next earnings date?

DexCom is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.61 USD and revenue estimate of 1.29B.

Did DXCM beat earnings last quarter?

In its 2026-04-30 report, DXCM posted EPS of 0.56 USD versus a 0.4656 USD estimate — a beat of 20.3%.

What is DXCM's earnings track record?

Over the last 8 reported quarters with consensus data, DXCM beat estimates 6 times (75%).

What is DXCM's current P/E ratio and EPS?

DXCM trades at a trailing P/E of 29.76 on trailing EPS of 2.415995845235004 USD.

What do analysts rate DXCM?

Analyst consensus is "Buy" across 52 ratings (1 strong buy, 41 buy, 8 hold, 2 sell, 0 strong sell). Average 12-month price target: 83.2 USD.